| Adverse effect |
Odds ratio; 95% CI; heterogeneity; N of studies, N of participants |
P value |
| Alopecia |
OR 3.10, 95% CI 0.12 to 79.23; 1 study, 60 participants |
P = 0.49 |
| Constipation |
OR 7.76, 95% CI 0.38 to 157.14; 1 study, 60 participants |
P = 0.18 |
| Diarrhoea |
OR 5.35, 95% CI 0.25 to 116.31; 1 study, 60 participants |
P = 0.29 |
| Dizziness |
OR 2.74, 95% CI 0.63 to 11.82; 1 study, 60 participants |
P = 0.18 |
| Dry mouth |
OR 2.07, 95% CI 0.18 to 24.15; 1 study, 60 participants |
P = 0.56 |
| Dyspepsia |
OR 1.00, 95% CI 0.19 to 5.40; 1 study, 60 participants |
P = 1.00 |
| Headache |
OR 2.25, 95% CI 0.51 to 9.99; 1 study, 60 participants |
P = 0.29 |
| Increased appetite |
OR 7.76, 95% CI 0.38 to 157.14; 1 study, 60 participants |
P = 0.18 |
| Nausea |
OR 1.52, 95% CI 0.42 to 5.47; 1 study, 60 participants |
P = 0.52 |
| Pain in abdomen |
OR 13.16, 95% CI 0.69 to 249.48; 1 study, 60 participants |
P = 0.09 |
| Rash |
OR 3.10, 95% CI 0.12 to 79.23; 1 study, 60 participants |
P = 0.49 |
| Sedation |
OR 1.80, 95% CI 0.39 to 8.32; 1 study, 60 participants |
P = 0.45 |
| Thrombocytopenia |
OR 3.10, 95% CI 0.12 to 79.23; 1 study, 60 participants |
P = 0.49 |
| Vomiting |
OR 1.63, 95% CI 0.41 to 6.47; 1 study, 60 participants |
P = 0.49 |
| Weight gain |
OR 10.36, 95% CI 0.53 to 201.45; 1 study, 60 participants |
P = 0.12 |
